Video Center


The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

Published: 01 January 1970

Recent Videos: ASCO Conference Coverage

video

Real-World Evidence: Can It Drive Differentiation and Demonstrate 'Value'?

ZS’s Maria Whitman sat down with Dr. Yousuf Zafar, associate professor of medicine and public policy at Duke University, at ...

video

Evolving Immunotherapy Combinations

At ASCO 2017, ZS’s Sharon Karlsberg and Dr. Suzanne Topalian, associate director of the Johns Hopkins Bloomberg-Kimmel Institute for Cancer ...

video

Beyond PD-L1: In Search of Better Biomarkers

ZS’s Sharon Karlsberg sat down with Dr. Suzanne Topalian, Associate Director of the Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, ...

video

Practical Issues When Treating With Immunotherapy

ZS’s Sharon Karlsberg sat down with Dr. Suzanne Topalian, associate director of the Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, ...

video

Real-World Evidence as a Mechanism for Patient-Centric Care

ZS’s Maria Whitman sat down with Dr. Yousuf Zafar, associate professor of medicine and public policy at Duke University, at ...

video

Real-World Evidence Compared to Randomized Clinical Trials

ZS’s Maria Whitman sat down with Dr. Yousuf Zafar, associate professor of medicine and public policy at Duke University, at ...

video

Real-World Evidence Today and Tomorrow: The Role of Key Stakeholders

ZS’s Maria Whitman sat down with Dr. Yousuf Zafar, associate professor of medicine and public policy at Duke University, at ...

video

Mary Jo Fidler, MD, FASCO, offers opinion on integrating immunotherapies into treatment of SCLC

Dr. Fidler, Associate Professor, Medical Oncology, Rush University Medical Center, describes how immunotherapies should be integrated into the treatment of ...

video

Mary Jo Fidler, MD, FASCO, comments on the outlook for immunotherapy combinations in SCLC

Dr. Fidler, Associate Professor, Medical Oncology, Rush University Medical Center, speculates on the future of immunotherapy combinations when treating small ...

video

Mary Jo Fidler, MD, FASCO, considers the biomarker challenges when treating SCLC

Dr. Fidler, Associate Professor, Medical Oncology, Rush University Medical Center, elaborates on the challenges associated with biomarkers when treating small ...

Related Videos